These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 5322501
1. Treatment of hypertension with methyldopa. Johnson P, Kitchin AH, Lowther CP, Turner RW. Br Med J; 1966 Jan 15; 1(5480):133-7. PubMed ID: 5322501 [No Abstract] [Full Text] [Related]
2. Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension. Amery A, Verstraete M, Bossaert H, Verstreken G. Br Med J; 1970 Nov 14; 4(5732):392-5. PubMed ID: 4921284 [Abstract] [Full Text] [Related]
3. Clinical studies of methyldopa and its combination with chlorthalidone in hypertension. Singh S, Mathur MN, Bedi HK. Indian J Med Sci; 1967 Feb 14; 21(2):104-8. PubMed ID: 5341937 [No Abstract] [Full Text] [Related]
4. A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension. Tuomilehto J, Puska P, Mustaniemi H. Acta Med Scand Suppl; 1974 Feb 14; 554():47-54. PubMed ID: 4593673 [No Abstract] [Full Text] [Related]
5. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension. Channick BJ, Kessler WB, Marks AD, Adlin EV. Clin Ther; 1981 Feb 14; 4(3):175-83. PubMed ID: 7307035 [Abstract] [Full Text] [Related]
6. Clonidine versus methyldopa. A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect. Amery AK, Bossaert H, Fagard RH, Verstraete M. Acta Cardiol; 1972 Feb 14; 21(1):82-99. PubMed ID: 4553878 [No Abstract] [Full Text] [Related]
7. Autoantibodies related to treatment with chlorthalidone and alpha-methyldopa. Feltkamp TE, Mees EJ, Nieuwenhuis MG. Acta Med Scand; 1970 Mar 03; 187(3):219-23. PubMed ID: 4910696 [No Abstract] [Full Text] [Related]
8. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. Oates JA, Seligmann AW, Clark MA, Rousseau P, Lee RE. N Engl J Med; 1965 Sep 30; 273(14):729-34. PubMed ID: 5317954 [No Abstract] [Full Text] [Related]
9. Atenolol, methyldopa, and chlorthalidone in moderate hypertension. Webster J, Jeffers TA, Galloway DB, Petrie JC, Barker NP. Br Med J; 1977 Jan 08; 1(6053):76-8. PubMed ID: 12850 [Abstract] [Full Text] [Related]
10. Letter: Treatment for hypertension. du Burger PD. S Afr Med J; 1973 Sep 29; 47(38):1727. PubMed ID: 4745077 [No Abstract] [Full Text] [Related]
11. Moderate hypertension: treatment with guanethidine and methyldopa. Dunn MI, Freeman J. Curr Ther Res Clin Exp; 1975 Aug 29; 18(2):285-94. PubMed ID: 809241 [No Abstract] [Full Text] [Related]
12. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study. Glazer N. Curr Ther Res Clin Exp; 1975 Mar 29; 17(3):249-56. PubMed ID: 805019 [No Abstract] [Full Text] [Related]
13. Controlled trial of guanethidine and methyldopa in moderate hypertension. Tarpley EL. Curr Ther Res Clin Exp; 1974 Nov 29; 16(11):1187-96. PubMed ID: 4214653 [No Abstract] [Full Text] [Related]
14. Hypotensive drugs. II. General considerations. Br Med J; 1969 May 17; 2(5654):430-2. PubMed ID: 5781490 [No Abstract] [Full Text] [Related]
18. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3). Becker-Christensen F, Bang HO, Ditzel J. Acta Med Scand; 1971 May 17; 190(1-2):21-6. PubMed ID: 5099124 [No Abstract] [Full Text] [Related]
19. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension]. Glezer GA, Moskalenko NP. Kardiologiia; 1972 Dec 17; 12(12):55-60. PubMed ID: 4661921 [No Abstract] [Full Text] [Related]